A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia

Autor: Diaz-Padilla, Ivan, Wilson, Michelle K., Clarke, Blaise A., Hirte, Hal W., Welch, Stephen A., Mackay, Helen J., Biagi, Jim J., Reedijk, Michael, Weberpals, Johanne I., Fleming, Gini F., Wang, Lisa, Liu, Geoffrey, Zhou, Chen, Blattler, Chantale, Ivy, S. Percy, Oza, Amit M.
Zdroj: In Gynecologic Oncology May 2015 137(2):216-222
Databáze: ScienceDirect
Externí odkaz: